{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:31:12Z","timestamp":1791361872588,"version":"4.3.1"},"reference-count":0,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,8,28]]},"DOI":"10.1182\/blood-2001-12-0181","type":"journal-article","created":{"date-parts":[[2002,8,28]],"date-time":"2002-08-28T14:22:57Z","timestamp":1030544577000},"page":"1965-1971","source":"Crossref","is-referenced-by-count":461,"title":["A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias"],"prefix":"10.1182","volume":"100","author":[{"given":"O. G.","family":"Ottmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2002,5,24]]},"container-title":["Blood"],"original-title":[],"deposited":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T04:06:36Z","timestamp":1314072396000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.bloodjournal.org\/cgi\/doi\/10.1182\/blood-2001-12-0181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,24]]},"references-count":0,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1182\/blood-2001-12-0181","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5,24]]}}}